Solution Project Team
CEO – Martha Harlam
Finance – Catania Rodrieges – La Caixa Banco
Project Development – Barbara van der Kleij
Website / Media Development – Mark Ford
Lawyer and Legal Defense Protection Insurance – SB Insurance Barcelona
Mission Statement
The Solution Project is built on 3 principles that form the basis of its mission. It best describes our current goals . Gene therapy development is a major leader of our mission focus.
Medical research : Biotechnology, Pharmaceutical manufacturing, charities and public sector agencies all contribute to the development of the future of this field.
Education : Universities, specialized labs and Foundations are contributing to the success of the support of our mission. The USC San Diego has been working on Gene Therapy development for Friedrichs Ataxia.
Care ( rehabilitation and treatment ) Professionals and personal caregivers are all contributing to the forward development of the neurological movement care management.
Market Predictions : There is a company that is highly respected for its market predictions of actors in the neurological movement disorders market development. Gene therapy has grown to new heights.
Gene Therapy Initiative : The GTI at USC San Diego has developed a Foundation to support the work and research behind the Lab facility of Stephanie Cherqui. The main focus has been the development of Friedrichs Ataxia using CRISPR Methods .
Background Information on Gene Therapy Development
Gene Therapy and Gene Editing saw a surge in 2022. The Gene Therapy and Editing development saw a setback in development due to FDA regulations – especially for the practices of Biohaven . Pfizer did a buyout of Biohaven Gene Therapy initiatives and gave a boost to the entire sector.
SOLUTION PROJECT WORLDWIDE EXPANSION
Our ideals are looking for partnerships worldwide. Martha.harlam@icloud.com = email